Dec 03, 2024

How do I conduct better analysis?

I am an analyst at a private credit firm, with one year of BB commercial credit experience prior to this. Today I had a conversation with my manager, and he said he wants me to start digging deeper in my analysis and to start "thinking like an investor". 

My problem is most of my analysis is regurgitating financials. Anyone can do it. I don't seem to dive in deep enough to understand the company, industry, etc. I think what troubles me is when I get started with a new company to cover, I don't seem to know where to start. I am by no means an expert at an industry. For example, today I got added to cover a bio tech company. I don't know where to find relevant info about the industry, or what to start looking for. 

Could anyone share some advice as to how I can start improving my analysis from just being financials focused? Any tips, things to think about, or items that I should address as soon as I start covering a new company/industry?

Are resources like Seeking Alpha a good place to start if I wanted to learn about a company or industry that I start covering? Are there any other resources someone could recommend?

Thanks

10 Comments
 

To elevate your analysis and truly "think like an investor," here’s a structured approach based on the most helpful WSO content:

  1. Start with Company Fundamentals:

    • Dive into the company's history and filings. Read 2-3 years of 10-Ks, several 10-Qs, and at least 3-4 earnings call transcripts. This will give you a solid understanding of the company's operations, strategy, and financial trajectory.
    • Review event transcripts (e.g., conference presentations) and important 8-Ks for updates on material events.
    • Focus on management commentary and guidance changes between quarters to identify trends or shifts in strategy.
  2. Understand the Industry:

    • Read competitors' filings and earnings call transcripts to understand the broader industry landscape and competitive positioning.
    • Identify key macro forces driving the industry (e.g., regulatory changes, technological advancements, consumer trends).
    • For biotech specifically, familiarize yourself with the drug development pipeline, FDA approval processes, and key industry metrics like R&D spend and clinical trial success rates.
  3. Leverage External Resources:

    • Use Seeking Alpha, but focus on articles that provide deep insights rather than surface-level summaries. Combine this with sell-side research reports if you have access.
    • Speak with industry experts, consultants, or analysts to gain objective insights. Avoid relying too heavily on sell-side opinions, as they may not always align with investor perspectives.
    • Explore books or resources specific to the industry. For biotech, "The Billion-Dollar Molecule" or "Bad Blood" can provide context on the sector's dynamics.
  4. Develop an Investor Mindset:

    • Think about what drives the business over the next 12-36 months. Is it a good business in a good industry? What are the key risks and opportunities?
    • Identify 2-3 key KPIs that are critical to the company's performance. For biotech, this could include clinical trial milestones, cash burn rate, or partnerships with larger pharma companies.
    • Build a bull and bear thesis for the company. Understand what could go right or wrong and how it impacts valuation.
  5. Broaden Your Perspective:

    • Analyze companies outside your immediate coverage to develop a more diverse skill set. Volunteer for projects in other sectors or read reports from different industries.
    • Keep a diary of news and events for your covered companies. Note how the market reacts and what it means for the company’s financial outlook.
  6. Practical Tips for Starting Analysis:

    • Begin with company-provided information to form an independent opinion before layering in external data.
    • Use a structured approach to filter information. Focus on what matters most for the investment case rather than getting overwhelmed by every detail.

By following these steps, you’ll move beyond regurgitating financials and start delivering deeper, more insightful analysis. For additional guidance, check out the following WSO threads: - "Finishing 1st Year as HF Analyst - Ask Anything" (url: https://www.wallstreetoasis.com/forum/hedge-fund/finishing-1st-year-as-…) - "Q&A: HF Analyst @ $5bn+ Fund - Breaking In and Transition to Risk-Taking Role" (url: https://www.wallstreetoasis.com/forum/hedge-fund/qa-hf-analyst-5bn-fund…) - "Equity Research Q&A with Flake" (url: https://www.wallstreetoasis.com/forum/equity-research/equity-research-q…)

These resources provide actionable advice and insights from experienced professionals.

Sources: Guide To Evaluate a Biotech Company, Finishing 1st Year as HF Analyst - Ask Anything, Q&A: HF Analyst @ $5bn+ Fund - Breaking In and Transition to Risk-Taking Role, Learning Curve as 2nd Year Analyst, Finishing 1st Year as HF Analyst - Ask Anything

I'm an AI bot trained on the most helpful WSO content across 17+ years.
 
Most Helpful

The bot response is actually fairly good.  Assuming you're literally only getting financials for the prospective borrower (which don't include any management discussion & analysis / narrative), then a few thoughts come to mind: (1) check the company website and Google to see what you can find out about the company's products, has management spoken anywhere publicly about the business, are there any lawsuits which would impact the business and your ability to get repaid as a lender (example for biotech - does the company have any drug trials which need regulatory approvals to continue, but regulators have not given yet, or affirmatively denied, such approval - if approval is denied, does that impact revenue - is revenue impacted enough to leave insufficient cashflow to repay your loan - etc); (2) try to find comparable public companies, and read a few 10-Ks - are there similarities in how companies talk about their business?  Are there differences?  It's all a game of pattern-recognition, and the more examples you have to compare to, the better (learning about a new sector is always toughest for the first company you're looking at, but the process should speed up for subsequent companies because you already have a knowledge base); (3) compare margins across comparable companies and the target as a proxy for answering the question 'do these companies all have similar business models?'  You can compare financials across industries to get a sense for what different business models look like; (4) Google for industry news sources, and subscribe to those sources or use Google alert keywords; (5) think about what you learned about the company in (1) relative to the rest of these items... e.g., for a biotech company - what are its products, are any drugs under patent / what is the remaining period of patent protection, do any products still need regulatory approvals and if so, what does the company's future results look like if it does and does not get those approvals.  And take notes for the future, so if you have to come back to an industry you haven't covered for a while, you can refresh quickly - this also applies to your personal research process... if you're struggling with how to get started or what to look for, create a Word doc with a list, and build / revise it over time.  Look for X; try checking Y; etc.

There is a theme here - just start reading.  And take what information you do have, no matter how little, and work from there - biotech, Google, off to the races.  There is often no silver bullet source, just pulling together insights from various places.  Also, because you're in credit, the name of the game is 'don't lose money.'  So thinking about what can go wrong with the business can help you underwrite for potential downside... google for the industry plus bankruptcy as one way to learn what has historically happened to businesses in the sector when something goes wrong (and what can go wrong).  Googling "biotech bankruptcy," the first result I get is an article about all the biotech bankruptcy filings in 2023 from a site called "Fierce Biotech," which appears to be an industry news source.

 

Instead of jumping into the financials as soon as you are given a name, take a step back and first try to understand what the business does, the key drivers, how the business has been doing, and what the outlook is (what your thought is, how is the market viewing it, etc.). That will help you put the financials into perspective. I think a lot of this just comes with reps.. you will get better at it the longer you do it. 

 

I would say work backwards. Start by building out your credit thesis instead of analyzing the financials that were provided to you. From there, request for information that you need to confirm your thesis. 

Agree with others you get better with reps but there are some usual suspects. Customer concentration, recurring profits, contractual nature of the business, industry backdrop, market share, etc

 

Financials are really more of a red flag/green flag exercise than anything else, you should not be spending the bulk of your time on that. You need to develop a credit investing mindset which in my mind has 2 parts:

1. How do I get paid/exit? How is the business generating cash to pay your loan back? Cash flow? Asset Collateral?  TEV? If you need to sell how confident in your downside TEV? This should be a key driver of your thesis (e.g. low LTV, stable cash flow generation, etc.)
 

2. How do I lose money? This is more business model related than #1. What are the supply and demand drivers for the business? Who are their customers? Who are their suppliers? Who are their customers? Who are their competitors? Etc. etc. and then after you’ve identified the core drivers, what would need to happen to hurt the business? These are your key risks. It is also important to develop mitigants to these as well.

 

Probably a stupid question but when you're looking at asset collateral, do you mostly rely on audited balance sheet figures? Assuming you only really focus on more tangible assets + maybe IP, and disregard DTA style stuff?

 

Quo quia quod et laboriosam dignissimos quae id. Qui dolorum eos et. Consequatur pariatur et dolorum dicta omnis. Error possimus itaque quia dolorum. Et quo ab ut non architecto et odit accusantium.

Ad eum laudantium eos dolore repellendus ab. Voluptas impedit ducimus id voluptatem. Ullam quam et explicabo itaque. Earum nihil eos ut corrupti sapiente sunt et maiores. Aliquid soluta ipsum voluptatum. Odit et magni illo nihil dolorum ullam.

Career Advancement Opportunities

May 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.8%
  • JPMorgan 01 98.2%
  • Guggenheim Partners 01 97.6%
  • Morgan Stanley 07 97.1%

Overall Employee Satisfaction

May 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Morgan Stanley 01 98.8%
  • Evercore 01 98.2%
  • BMO Capital Markets 12 97.6%
  • Banco Santander 01 97.0%

Professional Growth Opportunities

May 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Evercore No 98.8%
  • Morgan Stanley 05 98.2%
  • JPMorgan No 97.6%
  • BMO Capital Markets 12 97.1%

Total Avg Compensation

May 2026 Investment Banking

  • Vice President (14) $434
  • Associates (43) $259
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (22) $179
  • Intern/Summer Associate (13) $156
  • 1st Year Analyst (75) $151
  • Intern/Summer Analyst (65) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
kanon's picture
kanon
99.0
3
BankonBanking's picture
BankonBanking
99.0
4
Secyh62's picture
Secyh62
99.0
5
DrApeman's picture
DrApeman
98.9
6
Betsy Massar's picture
Betsy Massar
98.9
7
dosk17's picture
dosk17
98.9
8
CompBanker's picture
CompBanker
98.9
9
GameTheory's picture
GameTheory
98.9
10
bolo up's picture
bolo up
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”